There were 1,571 press releases posted in the last 24 hours and 400,192 in the last 365 days.

Trupanion Reports First Quarter 2018 Results

SEATTLE, May 01, 2018 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2018.

“We had a solid start to the year, with strong revenue growth in both our subscription and other businesses,” said Darryl Rawlings, CEO of Trupanion. “We also continue to move the ball forward on our key strategic initiatives, including accelerating the deployment of Trupanion Express.”  

First Quarter 2018 Financial and Business Highlights

  • Total revenue was $69.8 million, an increase of 27% compared to the first quarter of 2017.
  • Total enrolled pets (including pets from our other business segment) was 446,533 at March 31, 2018, an increase of 23% over March 31, 2017.
  • Subscription business revenue was $61.5 million, an increase of 22% compared to the first quarter of 2017.
  • Subscription enrolled pets was 385,640 at March 31, 2018, an increase of 15% over March 31, 2017.
  • Net loss was $(1.5) million, or $(0.05) per basic and diluted share, flat with the first quarter of 2017.
  • Adjusted EBITDA was $0.4 million, compared to adjusted EBITDA of $0.5 million in the first quarter of 2017.
  • Operating cash flow was $2.1 million and free cash flow was $1.1 million, compared to operating cash flow of $1.9 million and free cash flow of $1.4 million in the first quarter of 2017.

Revenue by Quarter

A chart accompanying this announcement is available at 
http://resource.globenewswire.com/Resource/Download/82e51c71-c31f-44d5-ab81-0ea6ea2a2d83

Conference Call
Trupanion’s management will host a conference call today to review its first quarter 2018 results. The call is scheduled to begin shortly after 1:30 p.m. PT/ 4:30 p.m. ET. A live webcast will be accessible through the Investor Relations section of Trupanion’s website at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. Participants can access the conference call by dialing 1-877-407-0784 (United States) or 1-201-689-8560 (International). A telephonic replay of the call will also be available, one hour after the completion of the call, by dialing 1-844-512-2921 (United States) or 1-412-317-6671 (International) and entering the replay pin number: 13678512.

About Trupanion
Trupanion is a leader in medical insurance for cats and dogs throughout the United States and Canada. For almost two decades, Trupanion has helped provide peace of mind to pet owners so they can focus on their pet's recovery, not financial stress. Trupanion is committed to providing pet owners with the highest value in pet medical insurance. Trupanion is listed on NASDAQ under the symbol "TRUP". The company was founded in 2000 and is headquartered in Seattle, WA. Trupanion policies are issued, in the United States, by its wholly-owned insurance entity American Pet Insurance Company and, in Canada, by Omega General Insurance Company. For more information please visit Trupanion.com.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 relating to, among other things, expectations, plans, prospects and financial results for Trupanion, including, but not limited to, its expectations regarding its ability to execute its business plans. These forward-looking statements are based upon the current expectations and beliefs of Trupanion’s management as of the date of this press release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements made in this press release are based on information available to Trupanion as of the date hereof, and Trupanion has no obligation to update these forward-looking statements.

In particular, the following factors, among others, could cause results to differ materially from those expressed or implied by such forward-looking statements: the ability to achieve or maintain profitability and/or appropriate levels of cash flow in future periods; the ability to keep growing our membership base and revenue; the accuracy of assumptions used in determining appropriate member acquisition expenditures; the severity and frequency of claims; the ability to maintain high retention rates; the accuracy of assumptions used in pricing medical plan subscriptions and the ability to accurately estimate the impact of new products or offerings on claims frequency; actual claims expense exceeding estimates; regulatory and other constraints on the ability to institute, or the decision to otherwise delay, pricing modifications in response to changes in actual or estimated claims expense; the effectiveness and statutory or regulatory compliance of our Territory Partner model and of our Territory Partners, veterinarians and other third parties in recommending medical plan subscriptions to potential members; the ability to retain existing Territory Partners and increase the number of Territory Partners and active hospitals; compliance by us and those referring us members with laws and regulations that apply to our business, including the sale of a pet medical plan; the ability to maintain the security of our data; fluctuations in the Canadian currency exchange rate; the ability to protect our proprietary and member information; the ability to maintain our culture and team; the ability to maintain the requisite amount of risk-based capital; our ability to implement and maintain effective controls, including over financial reporting; the ability to protect and enforce Trupanion’s intellectual property rights; the ability to continue key contractual relationships with third parties; third-party claims including litigation and regulatory actions; the ability to recognize benefits from investments in new solutions and enhancements to Trupanion’s technology platform and website; and our ability to retain key personnel.

For a detailed discussion of these and other cautionary statements, please refer to the risk factors discussed in filings with the Securities and Exchange Commission (SEC), including but not limited to, Trupanion’s Annual Report on Form 10-K for the year ended December 31, 2017 and any subsequently filed reports on Forms 10-Q and 8-K. All documents are available through the SEC’s Electronic Data Gathering Analysis and Retrieval system at www.sec.gov or the Investor Relations section of Trupanion’s website at http://investors.trupanion.com.

Non-GAAP Financial Measures
Trupanion’s stated results may include certain non-GAAP financial measures. These non-GAAP financial measures may not provide information that is directly comparable to that provided by other companies in its industry as other companies in its industry may calculate or use non-GAAP financial measures differently. In addition, there are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with GAAP, may be different from non-GAAP financial measures used by other companies and exclude expenses that may have a material impact on Trupanion’s reported financial results. The presentation and utilization of non-GAAP financial measures is not meant to be considered in isolation or as a substitute for the directly comparable financial measures prepared in accordance with GAAP. Trupanion urges its investors to review the reconciliation of its non-GAAP financial measures to the most directly comparable GAAP financial measures in its consolidated financial statements, and not to rely on any single financial or operating measure to evaluate its business. These reconciliations are included below and on Trupanion’s Investor Relations website.

Because of varying available valuation methodologies, subjective assumptions and the variety of equity instruments that can impact a company’s non-cash expenses, Trupanion believes that providing various non-GAAP financial measures that exclude stock-based compensation expense and depreciation and amortization expense allows for more meaningful comparisons between its operating results from period to period. Trupanion offsets sales and marketing expense with sign-up fee revenue in the calculation of net acquisition cost because it collects sign-up fee revenue from new members at the time of enrollment and considers it to be an offset to a portion of Trupanion’s sales and marketing expenses. Trupanion believes this allows it to calculate and present financial measures in a consistent manner across periods. Trupanion’s management believes that the non-GAAP financial measures and the related financial measures derived from them are important tools for financial and operational decision-making and for evaluating operating results over different periods of time.

 

TRUPANION, INC.  
Consolidated Statements of Operations  
(in thousands, except per share data)  
             
  Three Months Ended  
  March 31,  
  2018     2017    
  (unaudited)  
Revenue:            
Subscription business $   61,517     $   50,229    
Other business     8,243         4,500    
Total revenue     69,760         54,729    
Cost of revenue:            
Subscription business (1)     51,014         41,246    
Other business     7,682         4,328    
  Total cost of revenue (2)     58,696         45,574    
Gross profit:            
Subscription business     10,503         8,983    
Other business     561         172    
Total gross profit     11,064         9,155    
Operating expenses:            
Technology and development (1)     2,164         2,403    
General and administrative (1)     4,458         4,012    
Sales and marketing (1)     5,938         4,089    
Total operating expenses     12,560         10,504    
Operating loss     (1,496 )       (1,349 )  
Interest expense     219         137    
Other (income) expense, net     (140 )       (28 )  
Loss before income taxes     (1,575 )       (1,458 )  
Income tax (benefit) expense     (95 )       24    
Net loss $   (1,480 )   $   (1,482 )  
             
Net loss per share:            
  Basic and diluted $   (0.05 )   $   (0.05 )  
Weighted-average common shares outstanding:            
  Basic and diluted     30,246,585         29,254,681    
             
(1) Includes stock-based compensation expense as follows:            
  Three Months Ended  
  March 31,  
  2018     2017    
Cost of revenue $   197     $   113    
Technology and development     49         50    
General and administrative     449         431    
Sales and marketing     273         187    
Total stock-based compensation expense $   968     $   781    
             
(2)The breakout of cost of revenue between veterinary invoice expense and other cost of revenue is as follows:  
             
  Three Months Ended  
  March 31,  
  2018     2017    
Veterinary invoice expense  $    50,113      $    39,187    
Other cost of revenue     8,583         6,387    
      Total cost of revenue  $    58,696      $    45,574    
             


   
TRUPANION, INC.  
Consolidated Balance Sheets  
(in thousands, except per share data)  
         
     
     
  March 31, 2018   December 31, 2017  
  (unaudited)      
Assets        
Current assets:        
Cash and cash equivalents $   30,786     $   25,706    
Short-term investments     39,360         37,590    
Accounts and other receivables     24,317         20,367    
Prepaid expenses and other assets     3,046         2,895    
Total current assets     97,509         86,558    
Restricted cash     600         600    
Long-term investments, at fair value     3,238         3,237    
Property and equipment, net     8,275         7,868    
Intangible assets, net     5,000         4,972    
Other long term assets     2,596         2,624    
Total assets $  117,218     $   105,859    
Liabilities and stockholders’ equity        
Current liabilities:        
Accounts payable $   3,343     $   2,716    
Accrued liabilities and other current liabilities     8,347         7,660    
Reserve for veterinary invoices     13,450         12,756    
Deferred revenue     26,757         22,734    
Total current liabilities     51,897         45,866    
Long-term debt     14,851         9,324    
Deferred tax liabilities     1,002         1,002    
Other liabilities     1,221         1,233    
Total liabilities     68,971         57,425    
Stockholders’ equity:        
Common stock, $0.00001 par value, 100,000,000 shares authorized; 31,181,627 and 30,430,915 shares issued and outstanding at March 31, 2018; 30,778,796 and 30,121,496 shares issued and outstanding at December 31, 2017     -          -     
Preferred stock: $0.00001 par value, 10,000,000 shares authorized; no shares issued and outstanding     -          -     
Additional paid-in capital    139,009         134,511    
Accumulated other comprehensive loss     (297 )       (92 )  
Accumulated deficit    (84,264 )       (82,784 )  
Treasury stock, at cost: 755,985 shares at March 31, 2018 and 657,300 shares at December 31, 2017     (6,201 )       (3,201 )  
Total stockholders’ equity     48,247         48,434    
Total liabilities and stockholders’ equity $  117,218     $   105,859    


   
   
TRUPANION, INC.  
Consolidated Statements of Cash Flows  
(in thousands)  
  Three Months Ended  
  March 31,  
    2018       2017    
  (unaudited)  
Operating activities        
Net loss $   (1,480 )   $   (1,482 )  
Adjustments to reconcile net loss to cash provided by operating activities:        
Depreciation and amortization     927         1,036    
Stock-based compensation expense     968         781    
Other, net     23         97    
Changes in operating assets and liabilities:        
Accounts and other receivables     (3,926 )       (3,372 )  
Prepaid expenses and other assets     (129 )       (219 )  
Accounts payable, accrued liabilities, and other liabilities     910         (295 )  
Reserve for veterinary invoices     743         1,093    
Deferred revenue     4,041         4,218    
Net cash provided by operating activities     2,077         1,857    
Investing activities        
Purchases of investment securities     (7,140 )       (5,172 )  
Maturities of investment securities     5,300         3,871    
Purchases of property and equipment     (992 )       (462 )  
Other investments     -          (2,710 )  
Net cash used in investing activities     (2,832 )       (4,473 )  
Financing activities        
Proceeds from exercise of stock options     481         1,037    
Proceeds from debt financing, net of financing fees     5,500         -     
Other financing     (216 )       (142 )  
Net cash provided by financing activities     5,765         895    
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash, net     70         21    
Net change in cash, cash equivalents, and restricted cash     5,080         (1,700 )  
Cash, cash equivalents, and restricted cash at beginning of period     26,306         24,237    
Cash, cash equivalents, and restricted cash at end of period $   31,386     $   22,537    
         


The following table sets forth our key operating metrics:                              
                                 
  Three Months Ended  
  Mar. 31,
2018
  Dec. 31,
2017
  Sep. 30,
2017
  Jun. 30,
2017
  Mar. 31,
2017
  Dec. 31,
2016
  Sep. 30,
2016
  Jun. 30,
2016
 
Total subscription pets enrolled (at period end)     385,640         371,683         359,102         346,409         334,909         323,233         312,282         299,856    
Total pets enrolled (at period end)     446,533         423,194         404,069         383,293         364,259         343,649         334,070         320,896    
Monthly average revenue per pet $   53.62     $   53.17     $   52.95     $   51.47     $   50.50     $   49.17     $   48.37     $   47.39    
Lifetime value of a pet (LVP) $   727     $   727     $   701     $   654     $   637     $   631     $   624     $   622    
Average pet acquisition cost (PAC) $   165     $   184     $   151     $   143     $   128     $   133     $   120     $   118    
Average monthly retention   98.63 %     98.63 %     98.61 %     98.57 %     98.58 %     98.60 %     98.61 %     98.64 %  
                                 


           
  The following table reflects the reconciliation of cash provided by operating activities to free cash flow (in thousands):  
           
    Three Months Ended  
    March 31,  
      2018       2017    
  Net cash provided by operating activities $   2,077     $   1,857    
  Purchases of property and equipment     (992 )       (462 )  
  Free cash flow $   1,085     $   1,395    


                   
  The following table reflects the reconciliation of GAAP measures to non-GAAP measures (in thousands, except percentages):  
                   
      Three Months Ended
March 31,
   
      2018     2017      
  Veterinary invoice expense   $   50,113     $   39,187      
  Stock-based compensation expense       (120 )       (70 )    
  Cost of goods   $   49,993     $   39,117      
  % of revenue     71.7 %     71.5 %    
                   
  Other cost of revenue   $   8,583     $   6,387      
  Stock-based compensation expense       (77 )       (43 )    
  Variable expenses   $   8,506     $   6,344      
  % of revenue     12.2 %     11.6 %    
                   
  Subscription gross profit   $   10,503     $   8,983      
  Stock-based compensation expense       197         113      
  Non-GAAP subscription gross profit   $   10,700     $   9,096      
  % of subscription revenue     17.4 %     18.1 %    
                   
  Gross profit   $   11,064     $   9,155      
  Stock-based compensation expense       197         113      
  Non-GAAP gross profit   $   11,261     $   9,268      
  % of revenue     16.1 %     16.9 %    
                   
  Technology and development expense   $   2,164     $   2,403      
  General and administrative expense       4,458         4,012      
  Depreciation and amortization expense       (927 )       (1,036 )    
  Stock-based compensation expense       (498 )       (481 )    
  Fixed expenses   $   5,197     $   4,898      
  % of revenue     7.4 %     8.9 %    
                   
  Sales and marketing expense   $   5,938     $   4,089      
  Stock-based compensation expense       (273 )       (187 )    
  Acquisition cost   $   5,665     $   3,902      
  % of revenue     8.1 %     7.1 %    
                   


The following table reflects the reconciliation of acquisition cost and net acquisition cost to sales and marketing expense (in thousands):        
                                     
    Three Months Ended  
    Mar. 31,
2018
  Dec. 31,
2017
  Sept. 30,
2017
  Jun. 30,
2017
  Mar. 31,
2017
  Dec. 31,
2016
  Sep. 30,
2016
  Jun. 30,
2016
   
Sales and marketing expenses   $   5,938     $   5,781     $   4,862     $   4,372     $   4,089     $   3,951     $   3,892     $   3,564      
Excluding:                                    
Stock-based compensation expense       (273 )       (172 )       (165 )       (198 )       (187 )       (113 )       (172 )       (165 )    
Acquisition cost       5,665         5,609         4,697         4,174         3,902         3,838         3,720         3,399      
Net of:                                    
Sign-up fee revenue       (616 )       (550 )       (558 )       (517 )       (544 )       (526 )       (525 )       (495 )    
Other business segment sales and marketing expense       (87 )       (56 )       (51 )       (63 )       (48 )       (62 )       (63 )       (55 )    
Net acquisition cost   $   4,962     $   5,003     $   4,088     $   3,594     $   3,310     $   3,250     $   3,132     $   2,849      
                                     


The following table reflects the reconciliation of adjusted EBITDA to net loss (in thousands):                    
                                     
    Three Months Ended  
    Mar. 31,
2018
  Dec. 31,
2017
  Sept. 30,
2017
  Jun. 30,
2017
  Mar. 31,
2017
  Dec. 31,
2016
  Sep. 30,
2016
  Jun. 30,
2016
   
Net loss   $   (1,480 )   $   (838 )   $   406     $   411     $   (1,482 )   $   (1,723 )   $  (1,637 )   $   (964 )    
Excluding:                                    
Stock-based compensation expense       968         855         895         888         781         731         776       743      
Depreciation and amortization expense       927         1,024         1,095         1,077         1,036         1,229         1,093       739      
Interest income       (132 )       (3 )       (97 )       (76 )       (51 )       (41 )       (29 )       (26 )    
Interest expense       219         163         124         109         137         81         66         41      
Income tax (benefit) expense       (95 )       (482 )       26         4         24         7         13         4      
(Gain) loss from equity method investment       -          -          -          (1,036 )       7         18         22         (15 )    
Adjusted EBITDA   $   407     $   719     $   2,449     $   1,377     $   452     $   302     $   304     $   522      
                                     

Contacts

Investors:
Laura Bainbridge, Addo Investor Relations
310.829.5400
InvestorRelations@trupanion.com

Media:
Scott Janzen, Trupanion Director of Communications
888.612.1138 ext 3450
scott.janzen@trupanion.com

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.